166 related articles for article (PubMed ID: 7477878)
1. Preproenkephalin and preprotachykinin messenger RNA expression in normal human basal ganglia and in Parkinson's disease.
Nisbet AP; Foster OJ; Kingsbury A; Eve DJ; Daniel SE; Marsden CD; Lees AJ
Neuroscience; 1995 May; 66(2):361-76. PubMed ID: 7477878
[TBL] [Abstract][Full Text] [Related]
2. Effects of L-DOPA on preproenkephalin and preprotachykinin gene expression in the MPTP-treated monkey striatum.
Herrero MT; Augood SJ; Hirsch EC; Javoy-Agid F; Luquin MR; Agid Y; Obeso JA; Emson PC
Neuroscience; 1995 Oct; 68(4):1189-98. PubMed ID: 8544992
[TBL] [Abstract][Full Text] [Related]
3. Preferential loss of preproenkephalin versus preprotachykinin neurons from the striatum of Huntington's disease patients.
Richfield EK; Maguire-Zeiss KA; Vonkeman HE; Voorn P
Ann Neurol; 1995 Dec; 38(6):852-61. PubMed ID: 8526457
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide messenger RNA expression in the 6-hydroxydopamine-lesioned rat striatum reinnervated by fetal dopaminergic transplants: differential effects of the grafts on preproenkephalin, preprotachykinin and prodynorphin messenger RNA levels.
Cenci MA; Campbell K; Björklund A
Neuroscience; 1993 Nov; 57(2):275-96. PubMed ID: 8115038
[TBL] [Abstract][Full Text] [Related]
5. Dopamine-opiate interaction in the regulation of neostriatal and pallidal neuronal activity as assessed by opioid precursor peptides and glutamate decarboxylase messenger RNA expression.
Mavridis M; Besson MJ
Neuroscience; 1999; 92(3):945-66. PubMed ID: 10426535
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of neuropeptide mRNA expression in intrastriatal striatal transplants by host dopaminergic afferents.
Campbell K; Wictorin K; Björklund A
Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10489-93. PubMed ID: 1438238
[TBL] [Abstract][Full Text] [Related]
7. Partial reversal of increased preproenkephalin messenger ribonucleic acid (mRNA) and decreased preprotachykinin mRNA by foetal dopamine cells in unilateral 6-hydroxydopamine-lesioned rat striatum parallels functional recovery.
Zeng BY; Jenner P; Marsden CD
Mov Disord; 1996 Jan; 11(1):43-52. PubMed ID: 8771066
[TBL] [Abstract][Full Text] [Related]
8. Chronic L-DOPA treatment differentially regulates gene expression of glutamate decarboxylase, preproenkephalin and preprotachykinin in the striatum of 6-hydroxydopamine-lesioned rat.
Zeng BY; Jolkkonen J; Jenner P; Marsden CD
Neuroscience; 1995 May; 66(1):19-28. PubMed ID: 7637869
[TBL] [Abstract][Full Text] [Related]
9. Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat.
Henry B; Crossman AR; Brotchie JM
Exp Neurol; 1999 Feb; 155(2):204-20. PubMed ID: 10072296
[TBL] [Abstract][Full Text] [Related]
10. Chronic blockade of muscarinic cholinergic receptors by systemic trihexyphenidyl (Artane) administration modulates but does not mediate the dopaminergic regulation of striatal prepropeptide messenger RNA expression.
Mavridis M; Rogard M; Besson MJ
Neuroscience; 1995 May; 66(1):37-53. PubMed ID: 7637873
[TBL] [Abstract][Full Text] [Related]
11. Thalamo-striatal deafferentation affects preproenkephalin but not preprotachykinin gene expression in the rat striatum.
Salin P; Kachidian P
Brain Res Mol Brain Res; 1998 Jun; 57(2):257-65. PubMed ID: 9675424
[TBL] [Abstract][Full Text] [Related]
12. Further characterization of preproenkephalin mRNA-containing cells in the rodent globus pallidus.
Hoover BR; Marshall JF
Neuroscience; 2002; 111(1):111-25. PubMed ID: 11955716
[TBL] [Abstract][Full Text] [Related]
13. Neonatal dopamine depletion reveals a synergistic mechanism of mRNA regulation that is mediated by dopamine(D1) and serotonin(2) receptors and is targeted to tachykinin neurons of the dorsomedial striatum.
Campbell BM; Gresch PJ; Walker PD
Neuroscience; 2001; 105(3):671-80. PubMed ID: 11516832
[TBL] [Abstract][Full Text] [Related]
14. Expression of D1 receptor, D2 receptor, substance P and enkephalin messenger RNAs in the neurons projecting from the nucleus accumbens.
Lu XY; Ghasemzadeh MB; Kalivas PW
Neuroscience; 1998 Feb; 82(3):767-80. PubMed ID: 9483534
[TBL] [Abstract][Full Text] [Related]
15. Glutamate decarboxylase-67 messenger RNA expression in normal human basal ganglia and in Parkinson's disease.
Nisbet AP; Eve DJ; Kingsbury AE; Daniel SE; Marsden CD; Lees AJ; Foster OJ
Neuroscience; 1996 Nov; 75(2):389-406. PubMed ID: 8931005
[TBL] [Abstract][Full Text] [Related]
16. Reduction in the ratio of beta-preprotachykinin to preproenkephalin messenger RNA expression in postmortem human putamen during aging and in patients with status lacunaris. Implications for the susceptibility to parkinsonism.
Tohgi H; Utsugisawa K; Yoshimura M; Yamagata M; Nagane Y; Saitoh K
Brain Res; 1997 Sep; 768(1-2):86-90. PubMed ID: 9369304
[TBL] [Abstract][Full Text] [Related]
17. Serotonin-2 receptor stimulation normalizes striatal preprotachykinin messenger RNA in an animal model of Parkinson's disease.
Gresch PJ; Walker PD
Neuroscience; 1999; 93(3):831-41. PubMed ID: 10473249
[TBL] [Abstract][Full Text] [Related]
18. Increase of preproenkephalin mRNA levels in the putamen of Parkinson disease patients with levodopa-induced dyskinesias.
Calon F; Birdi S; Rajput AH; Hornykiewicz O; Bédard PJ; Di Paolo T
J Neuropathol Exp Neurol; 2002 Feb; 61(2):186-96. PubMed ID: 11853020
[TBL] [Abstract][Full Text] [Related]
19. Striatal preprotachykinin and preproenkephalin mRNA levels and the levels of nigral substance P and pallidal Met5-enkephalin depend on corticostriatal axons that use the excitatory amino acid neurotransmitters aspartate and glutamate: quantitative radioimmunocytochemical and in situ hybridization evidence.
Somers DL; Beckstead RM
Brain Res Mol Brain Res; 1990 Jul; 8(2):143-58. PubMed ID: 1698246
[TBL] [Abstract][Full Text] [Related]
20. Deep brain stimulation of the center median-parafascicular complex of the thalamus has efficient anti-parkinsonian action associated with widespread cellular responses in the basal ganglia network in a rat model of Parkinson's disease.
Jouve L; Salin P; Melon C; Kerkerian-Le Goff L
J Neurosci; 2010 Jul; 30(29):9919-28. PubMed ID: 20660274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
